News
Biotechnology company Moderna (NASDAQ:MRNA) announced better-than-expected revenue in Q2 CY2025, but sales fell by 41.1% year ...
HHS Secretary Robert F. Kennedy Jr. has upended COVID vaccine approvals and recommendations, creating uncertainty where coverage was routine.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback